<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:oef="http://xbrl.sec.gov/oef/2025"
  xmlns:rdfi="http://rareviewcapital.com/20260427"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdfi-20260427.xsd" xlink:type="simple"/>
    <context id="AsOf2026-04-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001719812</identifier>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-04-27</endDate>
        </period>
    </context>
    <context id="From2026-04-272026-04-27_custom_S000069798Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001719812</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdfi:S000069798Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-04-27</endDate>
        </period>
    </context>
    <context id="From2026-04-272026-04-27_custom_C000222559Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001719812</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">rdfi:C000222559Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-27</startDate>
            <endDate>2026-04-27</endDate>
        </period>
    </context>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2026-04-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2026-04-27" id="Fact000004">497</dei:DocumentType>
    <dei:EntityInvCompanyType contextRef="AsOf2026-04-27" id="Fact000005">N-1A</dei:EntityInvCompanyType>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-04-27" id="Fact000006">0001719812</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2026-04-27" id="Fact000012">Collaborative Investment Series Trust</dei:EntityRegistrantName>
    <oef:SupplementToProspectusTextBlock
      contextRef="From2026-04-272026-04-27_custom_S000069798Member"
      id="Fact000013">&lt;p id="xdx_A8B_eoef--SupplementToProspectusTextBlock_zyTYheOqd5U6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: center; text-indent: -0.25in"&gt;&lt;b&gt;Supplement dated
&lt;span class="xdx_phnt_RG9jdW1lbnQgLSBGb3JtIE4tMUEgQ292ZXIA" id="xdx_90E_edei--DocumentPeriodEndDate_c20260427__20260427_z3jDxZVitkNk"&gt;April 27, 2026&lt;/span&gt; to the Prospectus and Summary Prospectus dated &lt;span id="xdx_909_eoef--ProspectusDate_c20260427__20260427_zzlowBDcsnTk"&gt;February 1, 2026&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"&gt;&lt;div style="border-top: black 1.5pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective May 1, 2026, the fee table on page 1 of
the Prospectus and page 1 of the Summary Prospectus is replaced with the following:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
</oef:SupplementToProspectusTextBlock>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-04-27" id="Fact000014">2026-04-27</dei:DocumentPeriodEndDate>
    <oef:ProspectusDate contextRef="AsOf2026-04-27" id="Fact000015">2026-02-01</oef:ProspectusDate>
    <oef:AnnualFundOperatingExpensesTableTextBlock
      contextRef="From2026-04-272026-04-27_custom_S000069798Member"
      id="Fact000016">&lt;div id="xdx_A87_eoef--AnnualFundOperatingExpensesTableTextBlock_zvjRSeXw0UWf"&gt;&lt;/div&gt;
&lt;table cellpadding="2" cellspacing="0" id="xdx_A5F_zQFEBve4FM2b" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 95%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - Annual Fund Operating Expenses"&gt;
  &lt;tr style="background-color: #DDDDDD"&gt;
    &lt;td id="xdx_98B_eoef--OperatingExpensesCaption_c20260427__20260427__dei--LegalEntityAxis__custom--S000069798Member_zmQFqI7gYzIg" style="border: black 1pt solid; width: 88%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Annual Fund Operating Expenses&lt;br/&gt;
&lt;/b&gt;&lt;i&gt;(expenses that you pay each year as a percentage of the value of your investment)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20260427__20260427__oef--ClassAxis__custom--C000222559Member_zBz61hiHRpgk" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 12%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eoef--ManagementFeesOverAssets_dp_zAEIpfzc6zDh"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management Fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.97%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eoef--DistributionAndService12b1FeesOverAssets_dp_zi5lHeXmbun8"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distribution
    and Service (12b-1) Fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eoef--OtherExpensesOverAssets_dp_zWeW9GwcAkEl"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other Expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.53%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eoef--AcquiredFundFeesAndExpensesOverAssets_dp_zVvm32B41yHf"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Acquired Fund Fees and Expenses&lt;sup id="xdx_F41_zVHZKKSikD0j"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.73%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eoef--ExpensesOverAssets_dp_zTswjFShiZ4l"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Annual Fund Operating Expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eoef--FeeWaiverOrReimbursementOverAssets_dp_zwq4p2dDvfU1"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fee Waiver and Expense Reimbursement&lt;sup id="xdx_F48_zNfHzoyWbmcg"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eoef--NetExpensesOverAssets_dp_ziq5L1mrXYhh"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Annual Fund Operating Expenses After Fee Waiver and Reimbursement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="1" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin: 0 auto; width: 95%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 9pt"&gt;&lt;sup id="xdx_F06_z7LGy5kEYnh9"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zmdJu7GRg9Ve" style="font-size: 9pt"&gt;&lt;span id="xdx_90F_eoef--AcquiredFundFeesAndExpensesBasedOnEstimates_c20260427__20260427__dei--LegalEntityAxis__custom--S000069798Member_zpdPI2D1epAd"&gt;Acquired Fund Fees and Expenses,
which are estimated for the Fund&#x2019;s current fiscal year, are the indirect costs of investing in other investment companies and not
a cost borne directly by the Fund.&lt;/span&gt; &lt;span id="xdx_90E_eoef--ExpensesNotCorrelatedToRatioDueToAcquiredFundFees_c20260427__20260427__dei--LegalEntityAxis__custom--S000069798Member_zPjFLEGm4tAc"&gt;The operating expenses in this fee table will not correlate to the expense ratio in the Fund&#x2019;s
financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.&lt;/span&gt; Excluding Acquired
Fund Fees and Expenses, Total Annual Fund Operating Expenses After Fee Waiver and Reimbursement are 1.50%. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="1" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin: 0 auto; width: 95%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 9pt"&gt;&lt;sup id="xdx_F06_zAY1xBCkv58k"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zQ4OFbmZ4xLe" style="font-size: 9pt"&gt;Rareview Capital LLC (the
&#x201c;Adviser&#x201d;) has contractually agreed to waive a portion or all of its management fees and/or reimburse Fund expenses (excluding
front-end or contingent deferred loads, Rule 12b-1 fees, shareholder servicing fees, acquired fund fees and expenses, taxes, leverage/borrowing
interest, interest expense, dividends on securities sold short, brokerage or other transactional expenses and extraordinary expenses)
in order to limit the Total Annual Fund Operating Expenses to 1.50% of average daily net assets of the Fund (the &#x201c;Expense Cap&#x201d;).
The Expense Cap will remain in effect through at least&#160;&lt;span id="xdx_904_eoef--FeeWaiverOrReimbursementOverAssetsDateOfTermination_c20260427__20260427__oef--ClassAxis__custom--C000222559Member_zjW0hkhI39f1"&gt;January 31, 2027&lt;/span&gt;&#160;and may be terminated at any time upon 60 days&#x2019;
written notice by the Trust&#x2019;s Board of Trustees (the &#x201c;Board&#x201d;). The Adviser may request recoupment of previously waived
fees and reimbursed expenses from the Fund for three years from the date they were waived or reimbursed, provided that after payment of
the recoupment, the Total Annual Fund Operating Expenses do not exceed the lesser of the Expense Limitation Agreement: (i) in effect at
the time of the waiver or reimbursement, or (ii) in effect at the time of recoupment.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</oef:AnnualFundOperatingExpensesTableTextBlock>
    <oef:OperatingExpensesCaption
      contextRef="From2026-04-272026-04-27_custom_S000069798Member"
      id="Fact000017">Annual Fund Operating Expenses
(expenses that you pay each year as a percentage of the value of your investment)</oef:OperatingExpensesCaption>
    <oef:ManagementFeesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000019"
      unitRef="Ratio">0.0097</oef:ManagementFeesOverAssets>
    <oef:DistributionAndService12b1FeesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000021"
      unitRef="Ratio">0.0000</oef:DistributionAndService12b1FeesOverAssets>
    <oef:OtherExpensesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000023"
      unitRef="Ratio">0.0053</oef:OtherExpensesOverAssets>
    <oef:AcquiredFundFeesAndExpensesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000025"
      unitRef="Ratio">0.0273</oef:AcquiredFundFeesAndExpensesOverAssets>
    <oef:ExpensesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000027"
      unitRef="Ratio">0.0423</oef:ExpensesOverAssets>
    <oef:FeeWaiverOrReimbursementOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000029"
      unitRef="Ratio">0.0000</oef:FeeWaiverOrReimbursementOverAssets>
    <oef:NetExpensesOverAssets
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      decimals="INF"
      id="Fact000031"
      unitRef="Ratio">0.0423</oef:NetExpensesOverAssets>
    <oef:AcquiredFundFeesAndExpensesBasedOnEstimates
      contextRef="From2026-04-272026-04-27_custom_S000069798Member"
      id="Fact000033">Acquired Fund Fees and Expenses,
which are estimated for the Fund&#x2019;s current fiscal year, are the indirect costs of investing in other investment companies and not
a cost borne directly by the Fund.</oef:AcquiredFundFeesAndExpensesBasedOnEstimates>
    <oef:ExpensesNotCorrelatedToRatioDueToAcquiredFundFees
      contextRef="From2026-04-272026-04-27_custom_S000069798Member"
      id="Fact000034">The operating expenses in this fee table will not correlate to the expense ratio in the Fund&#x2019;s
financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.</oef:ExpensesNotCorrelatedToRatioDueToAcquiredFundFees>
    <oef:FeeWaiverOrReimbursementOverAssetsDateOfTermination
      contextRef="From2026-04-272026-04-27_custom_C000222559Member"
      id="Fact000036">January 31, 2027</oef:FeeWaiverOrReimbursementOverAssetsDateOfTermination>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000032" xlink:label="Footnote000032" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_90F_eoef--AcquiredFundFeesAndExpensesBasedOnEstimates_c20260427__20260427__dei--LegalEntityAxis__custom--S000069798Member_zpdPI2D1epAd">Acquired Fund Fees and Expenses,
which are estimated for the Fund&#x2019;s current fiscal year, are the indirect costs of investing in other investment companies and not
a cost borne directly by the Fund.</xhtml:span><xhtml:span id="xdx_90E_eoef--ExpensesNotCorrelatedToRatioDueToAcquiredFundFees_c20260427__20260427__dei--LegalEntityAxis__custom--S000069798Member_zPjFLEGm4tAc">The operating expenses in this fee table will not correlate to the expense ratio in the Fund&#x2019;s
financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.</xhtml:span> Excluding Acquired
Fund Fees and Expenses, Total Annual Fund Operating Expenses After Fee Waiver and Reimbursement are 1.50%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Rareview Capital LLC (the
&#x201c;Adviser&#x201d;) has contractually agreed to waive a portion or all of its management fees and/or reimburse Fund expenses (excluding
front-end or contingent deferred loads, Rule 12b-1 fees, shareholder servicing fees, acquired fund fees and expenses, taxes, leverage/borrowing
interest, interest expense, dividends on securities sold short, brokerage or other transactional expenses and extraordinary expenses)
in order to limit the Total Annual Fund Operating Expenses to 1.50% of average daily net assets of the Fund (the &#x201c;Expense Cap&#x201d;).
The Expense Cap will remain in effect through at least&#160;<xhtml:span id="xdx_904_eoef--FeeWaiverOrReimbursementOverAssetsDateOfTermination_c20260427__20260427__oef--ClassAxis__custom--C000222559Member_zjW0hkhI39f1">January 31, 2027</xhtml:span>&#160;and may be terminated at any time upon 60 days&#x2019;
written notice by the Trust&#x2019;s Board of Trustees (the &#x201c;Board&#x201d;). The Adviser may request recoupment of previously waived
fees and reimbursed expenses from the Fund for three years from the date they were waived or reimbursed, provided that after payment of
the recoupment, the Total Annual Fund Operating Expenses do not exceed the lesser of the Expense Limitation Agreement: (i) in effect at
the time of the waiver or reimbursement, or (ii) in effect at the time of recoupment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>